In addition to confirming a role for glucocorticoids in controlling PD-1 expression in both mouse and humans NK cells, this study highlights the potential effect of corticosteroid treatment on PD-1 expression levels in cancer patients NK cells. This evidence concerns the gene PDCD1 and cancer.